Globus Medical, Inc. Share Price
Equities
GMED
US3795772082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.70 USD | -2.45% |
|
-4.83% | +4.82% |
| 09/12 | Analyst recommendations: Colgate-Palmolive, Confluent, Draftkings, PepsiCo, Warner Bros… |  |
| 04/12 | Globus Medical Insider Sold Shares Worth $1,668,780, According to a Recent SEC Filing | MT |
| Capitalization | 1.16TCr 988.53Cr 923.4Cr 868.8Cr 1.6TCr 1,05100Cr 1.75TCr 11TCr 4.18TCr 50TCr 4.35TCr 4.26TCr 1,80700Cr | P/E ratio 2025 * |
22.1x | P/E ratio 2026 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise value | 1.1TCr 940.81Cr 878.82Cr 826.86Cr 1.52TCr 1,00000Cr 1.66TCr 10TCr 3.98TCr 47TCr 4.14TCr 4.06TCr 1,72000Cr | EV / Sales 2025 * |
3.82x | EV / Sales 2026 * | 3.35x |
| Free-Float |
82.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Globus Medical, Inc.
| 1 day | -2.45% | ||
| 1 week | -4.83% | ||
| Current month | -4.77% | ||
| 1 month | +3.23% | ||
| 3 months | +47.60% | ||
| 6 months | +47.20% | ||
| Current year | +4.82% |
| 1 week | 86.09 |  | 90.91 |
| 1 month | 81.95 | | 92.48 |
| Current year | 51.79 | | 94.93 |
| 1 year | 51.79 | | 94.93 |
| 3 years | 43.38 | | 94.93 |
| 5 years | 43.38 | | 94.93 |
| 10 years | 19.25 | | 94.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Pfeil
CEO | Chief Executive Officer | 46 | 18/07/2025 |
Kyle Kline
DFI | Director of Finance/CFO | 40 | 18/07/2025 |
Brian Kearns
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Paul
CHM | Chairman | 58 | 01/03/2003 |
David Davidar
BRD | Director/Board Member | 59 | 01/03/2003 |
Daniel Lemaitre
BRD | Director/Board Member | 71 | 21/04/2011 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.01% | 2 M€ | +9.31% | - |
| 0.99% | 148 M€ | +19.11% | - |
| 0.44% | 5 M€ | 0.00% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.45% | -4.83% | +5.19% | +17.08% | 1.16TCr | |
| +1.77% | +0.30% | +10.65% | +12.49% | 22TCr | |
| +0.12% | -1.47% | +21.08% | +24.62% | 13TCr | |
| +0.44% | +1.87% | +48.98% | +109.66% | 6.71TCr | |
| +0.23% | +3.57% | -10.94% | -20.93% | 5.73TCr | |
| +1.79% | -0.02% | +18.70% | +72.96% | 5.19TCr | |
| -2.87% | +2.24% | -13.25% | -43.99% | 2.61TCr | |
| -0.28% | -4.36% | +17.54% | +26.48% | 2.47TCr | |
| -1.06% | -3.80% | +5.72% | -37.11% | 2.34TCr | |
| +0.63% | -2.38% | -24.21% | +16.21% | 2.19TCr | |
| Average | -0.17% | -0.89% | +7.95% | +17.75% | 6.3TCr | |
| Weighted average by Cap. | +0.66% | -0.06% | +13.34% | +23.82% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 288.92Cr 246.13Cr 229.92Cr 216.32Cr 398.26Cr 26TCr 435.09Cr 2.68TCr 1.04TCr 12TCr 1.08TCr 1.06TCr 45TCr | 311.59Cr 265.44Cr 247.95Cr 233.29Cr 429.5Cr 28TCr 469.22Cr 2.89TCr 1.12TCr 13TCr 1.17TCr 1.14TCr 49TCr |
| Net income | 54Cr 46Cr 43Cr 41Cr 75Cr 4.91TCr 82Cr 503.24Cr 195.21Cr 2.31TCr 203.29Cr 199.01Cr 8.44TCr | 46Cr 39Cr 37Cr 34Cr 63Cr 4.16TCr 69Cr 426.86Cr 165.58Cr 1.96TCr 172.44Cr 168.8Cr 7.16TCr |
| Net Debt | -56Cr -48Cr -45Cr -42Cr -77Cr -5.07TCr -84Cr -520.34Cr -201.83Cr -2.39TCr -210.2Cr -205.77Cr -8.73TCr | -116.48Cr -99Cr -93Cr -87Cr -160.56Cr -11TCr -175.41Cr -1.08TCr -419.67Cr -4.97TCr -437.06Cr -427.85Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/25/12 | 86.70 $ | -2.45% | 14,03,963 |
| 11/25/11 | 88.88 $ | +1.21% | 11,69,972 |
| 10/25/10 | 87.82 $ | -0.68% | 14,33,706 |
| 09/25/09 | 88.42 $ | -0.65% | 14,64,949 |
| 08/25/08 | 89.00 $ | -2.31% | 16,64,846 |
Delayed Quote Nyse, December 13, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMED Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition